Clinical Trials Browser

Carcinoid Tumor × Ramucirumab × Endocrine × Clear all

NCT02795858 2025-02-19

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Phase 2 Completed

43 enrolled 11 charts

Carcinoid Tumor